By Notice dated December 21, 2001, and published in the Federal Register on January 8, 2002, (67 FR 922), Cerilliant Corporation, 14050 Summit Drive #121, P.O. Box 80189, Austin, Texas 78708-0189, made application by renewal to the Drug Enforcement Administration to be registered as an importer of the basic classes of controlled substances listed below:
|Gamma hydroxybutyric acid (2010)||I|
|Start Printed Page 42059|
|Dextropropoxyphene, bulk (non-dosage forms) (9273)||II|
The firm plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards.
No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Cerilliant Corporation to import the above listed controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. This investigation included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to Section 1008(a) of the Controlled Substances Import and Export Act and in accordance with Title 21, Code of Federal Regulations, Section 1301.34, the above firm is granted registration as an importer of the basic classes of controlled substances listed above.Start Signature
Dated: June 7, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 02-15563 Filed 6-19-02; 8:45 am]
BILLING CODE 4410-09-M